Fiche centre
Vancouver General Hospital
Vancouver — Canada
Essais liés2clinical trials
VilleVancouverlocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT00312273
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Aminophylline (250mg IV +/- a second dose of 250mg IV) | SEP | Phase 2 | NCT00312273 | Aminophylline in Bradyasystolic Cardiac Arrest | COMPLETED |
| CC-97540 | Lupus | Phase 2 | NCT07015983 | A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE) | ACTIVE_NOT_RECRUITING |